Publication | Closed Access

Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)

HypertensionLipid-lowering TreatmentCardiovascular DiseaseCardiovascular PharmacologyHeart Attack TrialPharmacotherapyAcute Myocardial InfarctionAtrial FibrillationPublic HealthMedicineCardiologyEmergency MedicineAnesthesiology